Search
for
Sort by
Research 121–150 of 1000+
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist
- Quality of Life in Slovak Breast Cancer Survivors: A Cross-Sectional Study Using EORTC QLQ-C30 and BR23
- Cold Atmospheric Plasma for Breast Cancer
- Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Impact of Chemotherapeutic Drug on People living with Cancer
- [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Hair loss during and after breast cancer therapy
- TGFβ and cancer metastasis: an inflammation link
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Approaches to management of endocrine therapy–induced alopecia in breast cancer patients
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- SAT-724 Persistently Elevated Alkaline Phosphatase in an Older Woman with a History of Breast Cancer
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)